U.S. Department of Defense issued a ‘COVID-19 Research’ contract 3 Months before COVID-19 was known to officially exist

The contract was part of a larger project for a “Biological threat reduction program in Ukraine,” suggesting that the U.S. Government was at the very least aware of the virus before it spread through Wuhan, China in December 2019, and before it was officially named Covid-19 by the World Health Organization in February 2020.

These findings raise concerns about the Government’s handling of the pandemic and the potential for a cover-up.

The U.S. Government’s “USA Spending” website reveals that it had spent a staggering $4.04 trillion “in response to COVID-19”. A deeper look at the website’s “Award Search” feature uncovers a contract awarded by the Department of Defense to Black & Veatch Special Projects Corp. for “Professional, Scientific, and Technical Services” on September 20, 2012.

A closer examination of the contract’s “Sub-Awards” tab reveals 115 transactions with recipients and brief descriptions, the majority of which are mundane items like “laboratory equipment for Kyiv” and “office furniture for Kyiv.”

There is, however, among the 115 transactions listed in the “Sub-Awards” tab of a contract awarded by the U.S. Department of Defense to Black & Veatch Special Projects Corp. one transaction that stands out:

An award to Labyrinth Global Health INC for “SME Manuscript Documentation and COVID-19 Research.”

While it is not surprising to see an award for Covid-19 research during a pandemic, the fact that the contract was awarded on November 12, 2019, at least one month before the alleged emergence of the novel coronavirus and three months before it was officially named Covid-19, raises questions about the government’s knowledge of the virus.

Furthermore, the contract was instructed to take place in Ukraine, as was the entire contract awarded to Black & Veatch Special Projects Corp. These findings suggest potential U.S. Government involvement in the creation and spread of the virus.

In September 2012, the Defense Threat Reduction Agency (DTRA) within the US Department of Defense awarded a contract to a global engineering, procurement, and construction company specializing in infrastructure development.

The contract was for a Biological threat reduction program in Ukraine, and concluded in October 2020. While the details are unclear, it is known that $21.7 million of the $116.6 million contract was spent on this program.

It is puzzling why the DOD would contract a company specializing in infrastructure development for a biological threat reduction program.

Furthermore, it is intriguing that both the DOD and the contracting company subsequently paid Labyrinth Global Health INC to conduct COVID-19 research in Ukraine prior to the emergence of the novel coronavirus and before it was officially named Covid-19.

These events raise questions about the nature of the biological threat reduction program and its potential connection to the alleged COVID-19 pandemic. And the discovery of a contract awarded by the U.S. Department of Defense for Covid-19 research in November 2019 suggests that the U.S Government either knew the virus existed naturally or was involved in constructing it in a lab.

This theory is supported by evidence that the National Institute of Allergy & Infectious Diseases (NIAID) and Moderna had a coronavirus candidate in December 2019.

A confidentiality agreement reveals that NIAID and Moderna agreed to transfer “mRNA coronavirus vaccine candidates” to the University of North Carolina at Chapel Hill on December 12, 2019.

The material transfer agreement was signed the December 12th 2019 by Ralph Baric, PhD, at the University of North Carolina at Chapel Hill, and then signed by Jacqueline Quay, Director of Licensing and Innovation Support at the University of North Carolina on December 16th 2019.

The agreement was also signed by two representatives of the NIAID, one of whom was Amy F. Petrik PhD, a technology transfer specialist who signed the agreement on December 12th 2019 at 8:05 am. The other signatory was Barney Graham MD PhD, an investigator for the NIAID, however, this signature was not dated.

The final signatories on the agreement were Sunny Himansu, Moderna’s Investigator, and Shaun Ryan, Moderna’s Deputy General Counsel. Both signatures were made on December 17th 2019.

All of these signatures were made prior to the general public having any knowledge of the alleged emergence of the novel coronavirus.

It wasn’t until December 31st 2019 that the World Health Organisation (WHO) became aware of an alleged cluster of viral pneumonia cases in Wuhan, China.

But even at this point, they had not determined that an alleged new coronavirus was to blame, instead stating the pneumonia was of “unknown cause”.

It was not until January 9th 2020 that the WHO reported Chinese authorities had determined the outbreak was due to a novel coronavirus which later became known as SARS-CoV-2 with the alleged resultant disease dubbed COVID-19.

So why was an mRNA coronavirus vaccine candidate developed by Moderna being transferred to the University of North Carolina on December 12th 2019?

The same Moderna that have had an mRNA coronavirus vaccine authorised for emergency use only in both the United Kingdom and United States to allegedly combat Covid-19.

What did Moderna know that we didn’t? In 2019 there was not any singular coronavirus posing a threat to humanity which would warrant a vaccine.

As the world tries to move on from the alleged Covid-19 pandemic, there are many questions that remain unanswered.

What caused the alleged outbreak? Was it naturally occurring, or was it the result of human intervention?

The discovery of a contract awarded by the U.S. Department of Defense for Covid-19 research in November 2019 suggests that the U.S Government knows the answer to those questions.

Join: 👉  https://t.me/acnewspatriots

The opinions expressed by contributors and/or content partners are their own and do not necessarily reflect the views of AC.NEWS

Disclaimer: This article may contain statements that reflect the opinion of the author. The contents of this article are of sole responsibility of the author(s). AC.News will not be responsible for any inaccurate or incorrect statement in this article www.ac.news websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner. Reprinting this article: Non-commercial use OK. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.

Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.